Membranous and crescentic glomerulonephritis in a patient with anti-nuclear and anti-neutrophil cytoplasmic antibodies

Kidney International

Volumn 71, Issue 4, 2007, Pages 360-365

  Chang, A ^a   Aneziokoro, O ^a   Meehan, S M ^a   Quigg, R J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANTINUCLEAR ANTIBODY; CREATININE; GRANULOCYTE ANTIBODY; HYDROCHLOROTHIAZIDE; LOSARTAN; POTASSIUM CHLORIDE;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; BLOOD PRESSURE; CASE REPORT; CREATININE BLOOD LEVEL; FEMALE; HOSPITALIZATION; HUMAN; HYPERTENSION; LABORATORY TEST; MEMBRANOUS GLOMERULONEPHRITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; SEROLOGY; ULTRASOUND; URINALYSIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, ANTINUCLEAR; DIAGNOSIS, DIFFERENTIAL; FEMALE; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; KIDNEY GLOMERULUS; MIDDLE AGED;

EID: 33846880438     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5001957     Document Type: Article

References (33)

1. Austin HA, Illei GG. Membranous lupus nephritis. Lupus 2005; 14: 65-71.
2. Baranowska-Daca E, Choi YJ, Barrios R et al. Nonlupus nephritides in patients with systemic lupus erythematosus: a comprehensive clinicopathologic study and review of the literature. Hum Pathol 2001; 32: 1125-1135.
3. Mac-Moune Lai F, Li EK, Tang NL et al. IgA nephropathy: a rare lesion in systemic lupus erythematosus. Mod Pathol 1995; 8: 5-10.
4. Magasic MV, Venkataseshan VS, Vitting KE. Concurrent renal sarcoidosis and lupus nephritis. Nephron 1993; 64: 496-497.
5. Singh NP, Prakash A, Sridhara G et al. Renal and systemic amyloidosis in systemic lupus erythematosus. Renal Failure 2003; 25: 671-675.
6. Dube GK, Markowitz GS, Radhakrishnan J et al. Minimal change disease in systemic lupus erythematosus. Clin Nephrol 2002; 57: 120-126.
7. Kraft SW, Schwartz MM, Korbet SM, Lewis EJ. Glomerular podocytopathy in patients with systemic lupus erythematosus. J Am Soc Nephrol 2005; 16: 175-179.
8. Akhtar M, al-Dalaan A, el-Ramahi KM. Pauci-immune necrotizing lupus nephritis: report of two cases. Am J Kidney Dis 1994; 23: 320-325.
9. Marshall S, Dressler R, D'Agati V. Membranous lupus nephritis with antineutrophil cytoplasmic antibody-associated segmental necrotizing and crescentic glomerulonephritis. Am J Kidney Dis 1997; 29: 119-124.
10. Masani NN, Imbriano LJ, D'Agati VD, Markowitz GS. SLE and rapidly progressive glomerulonephritis. Am J Kidney Dis 2005; 45: 950-955.
11. Schwartz MM, Roberts JL, Lewis EJ. Necrotizing glomerulitis of systemic lupus erythematosus. Hum Pathol 1983; 14: 158-167.
12. Ferrario F, Napodano P, Giordano A et al. Peculiar type of focal and segmental lupus glomerulitis: glomerulonephritis or vasculitis? Contrib Nephrol 1992; 99: 86-93.
13. Sen D, Isenberg DA. Antineutrophil cytoplasmic autoantibodies in systemic lupus erythematosus. Lupus 2003; 12: 651-658.
14. Xiao H, Heeringa P, Hu P et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 2002; 110: 955-963.
15. Schlieben DJ, Korbet SM, Kimura RE et al. Pulmonary-renal syndrome in a newborn with placental transmission of ANCAs. Am J Kidney Dis 2005; 45: 758-761.
16. Lee SS, Lawton JW, Chan CE et al. Antilactoferrin antibody in systemic lupus erythematosus. Br J Rheumatol 1992; 31: 669-673.
17. Sinico RA, Pozzi C, Radice A, Tincani A. ANCA with specificity for lactoferrin in systemic lupus erythematosus (SLE). Adv Exp Med Biol 1993; 336: 385-387.
18. Schnabel A, Csernok E, Isenberg DA et al. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Prevalence, specificities, and clinical significance. Arthritis Rheum 1995; 38: 633-637.
19. Spronk PE, Bootsma H, Horst G et al. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Br J Rheumatol 1996; 35: 625-631.
20. Nishiya K, Chikazawa H, Nishimura S et al. Anti-neutrophil cytoplasmic antibody in patients with systemic lupus erythematosus is unrelated to clinical features. Clin Rheumatol 1997; 16: 70-75.
21. Manolova I, Dancheva M, Halacheva K. Antineutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus: prevalence, antigen specificity, and clinical associations. Rheumatol Int 2001; 20: 197-204.
22. Zhao MH, Liu N, Zhang YK, Wang HY. Antineutrophil cytoplasmic autoantibodies (ANCA) and their target antigens in Chinese patients with lupus nephritis. Nephrol Dial Transplant 1998; 13: 2821-2824.
23. Chin HJ, Ahn C, Lim CS et al. Clinical implications of antineutrophil cytoplasmic antibody test in lupus nephritis. Am J Nephrol 2000; 20: 57-63.
24. Pradhan VD, Badakere SS, Bichile LS, Almeida AF. Anti-neutrophil cytoplasmic antibodies (ANCA) in systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies. J Assoc Physicians India 2004; 52: 533-537.
25. Caccavo D, Rigon A, Picardi A et al. Anti-lactoferrin antibodies in systemic lupus erythematosus: isotypes and clinical correlates. Clin Rheumatol 2005; 24: 381-387.
26. Hill GS, Delahousse M, Nochy D, Bariety J. Class IV-S versus class IV-G lupus nephritis: clinical and morphologic differences suggesting different pathogenesis. Kidney Int 2005; 68: 2288-2297.
27. Mittal B, Hurwitz S, Rennke H, Singh AK. New subcategories of class IV lupus nephritis: are there clinical, histologic, and outcome differences? Am J Kidney Dis 2004; 44: 1050-1059.
28. Cybulsky AV, Quigg RJ, Salant DJ. Experimental membranous nephropathy redux. Am J Physiol Renal Physiol 2005; 289: F660-F671.
29. Debiec H, Guigonis V, Mougenot B et al. Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N Engl J Med 2002; 346: 2053-2060.
30. de Groot K, Adu D, Savage CO. The value of pulse cyclophosphamide in ANCA-associated vasculitis: meta-analysis and critical review. Nephrol Dial Transplant 2001; 16: 2018-2027.
31. Balow JE, Austin III HA. Maintenance therapy for lupus nephritis - something old, something new. N Engl J Med 2004; 350: 1044-1046.
32. Rose BD, Appel GB, Kaplan AA, Stone JH. Initial and maintenance therapy of Wegener's granulomatosis and microscopic polyangitis, in, 2006, 14.2, Waltham, MA.
33. Pusey CD, Rees AJ, Evans DJ et al. Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies. Kidney Int 1991; 40: 757-763.